Search Results

There are 25045 results for: content related to: Immunotherapy of cancer in 2012

  1. Cancer Immunotherapy: Sipuleucel-T and Beyond

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 31, Issue 8, August 2011, Pages: 813–828, Dr. Aimee E. Hammerstrom, Dr. Diana H. Cauley, Dr. Bradley J. Atkinson and Dr. Padmanee Sharma

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.31.8.813

  2. You have free access to this content
    Sipuleucel-T (Provenge®) for castration-resistant prostate cancer

    BJU International

    Volume 110, Issue 2b, July 2012, Pages: E99–E104, Giuseppe Di Lorenzo, Matteo Ferro and Carlo Buonerba

    Version of Record online : 16 DEC 2011, DOI: 10.1111/j.1464-410X.2011.10790.x

  3. You have free access to this content
    New developments in castrate-resistant prostate cancer

    BJU International

    Volume 109, Issue s6, June 2012, Pages: 22–32, N. Shore, M. Mason and Th. M. de Reijke

    Version of Record online : 4 JUN 2012, DOI: 10.1111/j.1464-410X.2012.11217.x

  4. You have free access to this content
    Clinical development of novel therapeutics for castration-resistant prostate cancer

    CA: A Cancer Journal for Clinicians

    Volume 62, Issue 5, September/October 2012, Pages: 299–308, Matthew D. Galsky, Alexander C. Small, Che-kai Tsao and William K. Oh

    Version of Record online : 24 APR 2012, DOI: 10.3322/caac.21141

  5. You have free access to this content
    Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer

    Cancer

    Volume 115, Issue 16, 15 August 2009, Pages: 3670–3679, Celestia S. Higano, Paul F. Schellhammer, Eric J. Small, Patrick A. Burch, John Nemunaitis, Lianng Yuh, Nicole Provost and Mark W. Frohlich

    Version of Record online : 17 JUN 2009, DOI: 10.1002/cncr.24429

  6. You have free access to this content
    Role of Immunotherapy in Castration-Resistant Prostate Cancer (CRPC)

    BJU International

    Volume 113, Issue 3, March 2014, Pages: 367–375, Cristina Suárez, Rafael Morales-Barrera, Victor Ramos, Isaac Núñez, Claudia Valverde, Jacques Planas, Juan Morote, Xavier Maldonado and Joan Carles

    Version of Record online : 12 APR 2013, DOI: 10.1111/bju.12110

  7. You have free access to this content
    Urologists and oncologists: adapting to a new treatment paradigm in castration-resistant prostate cancer (CRPC)

    BJU International

    Volume 110, Issue 3, August 2012, Pages: 328–335, A. Oliver Sartor and John M. Fitzpatrick

    Version of Record online : 19 JUN 2012, DOI: 10.1111/j.1464-410X.2011.10818.x

  8. You have free access to this content
    A pharmacologic perspective on newly emerging T-cell manipulation technologies

    British Journal of Clinical Pharmacology

    Volume 76, Issue 2, August 2013, Pages: 173–187, Dominic Smethurst

    Version of Record online : 23 JUL 2013, DOI: 10.1111/j.1365-2125.2012.04475.x

  9. You have free access to this content
    Optimizing the care of patients with advanced prostate cancer in the UK: current challenges and future opportunities

    BJU International

    Volume 110, Issue 5, September 2012, Pages: 658–667, Heather Payne, Amit Bahl, Malcolm Mason, Janis Troup and Johann De Bono

    Version of Record online : 19 MAR 2012, DOI: 10.1111/j.1464-410X.2011.10886.x

  10. You have free access to this content
    Emerging and second line therapies for the management of metastatic castration-resistant prostate cancer: The Australian perspective

    Asia-Pacific Journal of Clinical Oncology

    Volume 8, Issue 1, March 2012, Pages: 31–42, Phillip PARENTE, Francis PARNIS and Howard GURNEY

    Version of Record online : 28 FEB 2012, DOI: 10.1111/j.1743-7563.2011.01506.x

  11. You have free access to this content
    HOW DOES SIPULEUCEL-T ALTER OUR CLINICAL PRACTICE?

    BJU International

    Volume 106, Issue 7, October 2010, Pages: 945–946, Daniel George

    Version of Record online : 14 SEP 2010, DOI: 10.1111/j.1464-410X.2010.09642.x

  12. First-line non-cytotoxic therapy in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: a systematic review of ten randomised clinical trials

    BJU International

    Accepted manuscript online: 6 JAN 2017, Michiel H.F. Poorthuis, Robin W.M. Vernooij, R. Jeroen A. van Moorselaar and Theo M. de Reijke

    DOI: 10.1111/bju.13764

  13. You have free access to this content
    Prostate cancer immunology – an update for Urologists

    BJU International

    Volume 107, Issue 7, April 2011, Pages: 1046–1051, Nieroshan Rajarubendra, Nathan Lawrentschuk, Damien M. Bolton, Laurence Klotz and Ian D. Davis

    Version of Record online : 10 NOV 2010, DOI: 10.1111/j.1464-410X.2010.09820.x

  14. You have free access to this content
    Castration-resistant prostate cancer: Many treatments, many options, many challenges ahead

    Cancer

    Volume 118, Issue 10, 15 May 2012, Pages: 2583–2593, Jorge A. Garcia and Brian I. Rini

    Version of Record online : 28 OCT 2011, DOI: 10.1002/cncr.26582

  15. You have free access to this content
    Immunotherapy and endothelin receptor antagonists for treatment of castration-resistant prostate cancer

    International Journal of Cancer

    Volume 133, Issue 7, 1 October 2013, Pages: 1743–1750, Ning Shao, Yang Wang, Wen Yu Jiang, Di Qiao, Shi Ge Zhang, Ye Wu, Xiang Xiang Zhang, Jiu Ling Wang, Yi Ding and Ning Han Feng

    Version of Record online : 8 APR 2013, DOI: 10.1002/ijc.28162

  16. You have free access to this content
    Clinical trial risk in castration-resistant prostate cancer: immunotherapies show promise

    BJU International

    Volume 113, Issue 5b, May 2014, Pages: E82–E89, Alessandro Tenuta, Laurence Klotz and Jayson L. Parker

    Version of Record online : 2 DEC 2013, DOI: 10.1111/bju.12309

  17. You have free access to this content
    Landmarks in non-hormonal pharmacological therapies for castration-resistant prostate cancer

    BJU International

    Volume 110, Issue s1, October 2012, Pages: 14–22, Noel W. Clarke

    Version of Record online : 10 OCT 2012, DOI: 10.1111/j.1464-410X.2012.11430.x

  18. You have free access to this content
    IMPROVED SURVIVAL PROSPECTS FOR PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER

    BJU International

    Volume 107, Issue 5, March 2011, Pages: 697–700, Roger S. Kirby and John M. Fitzpatrick

    Version of Record online : 11 FEB 2011, DOI: 10.1111/j.1464-410X.2010.10027.x

  19. You have free access to this content
    Immunotherapy for prostate cancer: the next step?

    Trends in Urology & Men's Health

    Volume 7, Issue 2, March/April 2016, Pages: 28–32, Hannah Rush, Clare Gilson and Simon Chowdhury

    Version of Record online : 4 APR 2016, DOI: 10.1002/tre.514

  20. You have free access to this content
    New clinical advances in immunotherapy for the treatment of solid tumours

    Immunology

    Volume 145, Issue 2, June 2015, Pages: 182–201, Valentina A. Zavala and Alexis M. Kalergis

    Version of Record online : 30 MAR 2015, DOI: 10.1111/imm.12459